Revision of Kite Pharma
syncWikidata syncChanges
| Field | Before | After |
|---|---|---|
| Description | — | Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017. |
| Type | — | organization |